Results
|
|
81.
|
Prognostic significance of cathepsins B and L in primary human breast cancer. [electronic resource] by
- Foekens, J A
- Kos, J
- Peters, H A
- Krasovec, M
- Look, M P
- Cimerman, N
- Meijer-van Gelder, M E
- Henzen-Logmans, S C
- van Putten, W L
- Klijn, J G
Producer: 19980324
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
|
82.
|
Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours. [electronic resource] by
- de Witte, J H
- Foekens, J A
- Brünner, N
- Heuvel, J J
- van Tienoven, T
- Look, M P
- Klijn, J G
- Geurts-Moespot, A
- Grebenchtchikov, N
- Benraad, T
- Sweep, C G
Producer: 20010809
In:
British journal of cancer vol. 85
Availability: No items available.
|
|
|
83.
|
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. [electronic resource] by
- Berns, E M
- Klijn, J G
- van Putten, W L
- de Witte, H H
- Look, M P
- Meijer-van Gelder, M E
- Willman, K
- Portengen, H
- Benraad, T J
- Foekens, J A
Producer: 19980127
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
|
84.
|
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. [electronic resource] by
- Nooter, K
- Brutel de la Riviere, G
- Look, M P
- van Wingerden, K E
- Henzen-Logmans, S C
- Scheper, R J
- Flens, M J
- Klijn, J G
- Stoter, G
- Foekens, J A
Producer: 19970917
In:
British journal of cancer vol. 76
Availability: No items available.
|
|
|
85.
|
Genetic alterations in ovarian borderline tumours and ovarian carcinomas. [electronic resource] by
- Schuyer, M
- Henzen-Logmans, S C
- van der Burg, M E
- Fieret, J H
- Derksen, C
- Look, M P
- Meijer-van Gelder, M E
- Klijn, J G
- Foekens, J A
- Berns, E M
Producer: 19990617
In:
European journal of obstetrics, gynecology, and reproductive biology vol. 82
Availability: No items available.
|
|
|
86.
|
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer. [electronic resource] by
- de Witte, J H
- Sweep, C G
- Klijn, J G
- Grebenschikov, N
- Peters, H A
- Look, M P
- van Tienoven, T H
- Heuvel, J J
- Bolt-De Vries, J
- Benraad, T J
- Foekens, J A
Producer: 19990707
In:
British journal of cancer vol. 80
Availability: No items available.
|
|
|
87.
|
Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients. [electronic resource] by
- de Witte, J H
- Sweep, C G
- Klijn, J G
- Grebenschikov, N
- Peters, H A
- Look, M P
- van Tienoven, T H
- Heuvel, J J
- van Putten, W L
- Benraad, T J
- Foekens, J A
Producer: 19990413
In:
British journal of cancer vol. 79
Availability: No items available.
|
|
|
88.
|
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. [electronic resource] by
- Foekens, J A
- Peters, H A
- Look, M P
- Portengen, H
- Schmitt, M
- Kramer, M D
- Brünner, N
- Jänicke, F
- Meijer-van Gelder, M E
- Henzen-Logmans, S C
- van Putten, W L
- Klijn, J G
Producer: 20000228
In:
Cancer research vol. 60
Availability: No items available.
|
|
|
89.
|
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer. [electronic resource] by
- Reijm, E A
- Jansen, M P H M
- Ruigrok-Ritstier, K
- van Staveren, I L
- Look, M P
- van Gelder, M E Meijer
- Sieuwerts, A M
- Sleijfer, S
- Foekens, J A
- Berns, E M J J
Producer: 20110628
In:
Breast cancer research and treatment vol. 125
Availability: No items available.
|
|
|
90.
|
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer. [electronic resource] by
- Jansen, M P H M
- Reijm, E A
- Sieuwerts, A M
- Ruigrok-Ritstier, K
- Look, M P
- Rodríguez-González, F G
- Heine, A A J
- Martens, J W
- Sleijfer, S
- Foekens, J A
- Berns, E M J J
Producer: 20121106
In:
Breast cancer research and treatment vol. 133
Availability: No items available.
|
|
|
91.
|
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer. [electronic resource] by
- Reijm, E A
- Timmermans, A M
- Look, M P
- Meijer-van Gelder, M E
- Stobbe, C K
- van Deurzen, C H M
- Martens, J W M
- Sleijfer, S
- Foekens, J A
- Berns, P M J J
- Jansen, M P H M
Producer: 20150703
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
92.
|
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. [electronic resource] by
- Berns, E M
- Foekens, J A
- Vossen, R
- Look, M P
- Devilee, P
- Henzen-Logmans, S C
- van Staveren, I L
- van Putten, W L
- Inganäs, M
- Meijer-van Gelder, M E
- Cornelisse, C
- Claassen, C J
- Portengen, H
- Bakker, B
- Klijn, J G
Producer: 20000511
In:
Cancer research vol. 60
Availability: No items available.
|
|
|
93.
|
Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. [electronic resource] by
- van der Burg, M E L
- Onstenk, W
- Boere, I A
- Look, M
- Ottevanger, P B
- de Gooyer, D
- Kerkhofs, L G M
- Valster, F A A
- Ruit, J B
- van Reisen, A G P M
- Goey, S H
- van der Torren, A M E
- ten Bokkel Huinink, D
- Kok, T C
- Verweij, J
- van Doorn, H C
Producer: 20141215
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
|
94.
|
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients. [electronic resource] by
- Mostert, B
- Sieuwerts, A M
- Kraan, J
- Bolt-de Vries, J
- van der Spoel, P
- van Galen, A
- Peeters, D J
- Dirix, L Y
- Seynaeve, C M
- Jager, A
- de Jongh, F E
- Hamberg, P
- Stouthard, J M L
- Kehrer, D F S
- Look, M P
- Smid, M
- Gratama, J W
- Foekens, J A
- Martens, J W M
- Sleijfer, S
Producer: 20160818
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
95.
|
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. [electronic resource] by
- Mateo, F
- Arenas, E J
- Aguilar, H
- Serra-Musach, J
- de Garibay, G Ruiz
- Boni, J
- Maicas, M
- Du, S
- Iorio, F
- Herranz-Ors, C
- Islam, A
- Prado, X
- Llorente, A
- Petit, A
- Vidal, A
- Català, I
- Soler, T
- Venturas, G
- Rojo-Sebastian, A
- Serra, H
- Cuadras, D
- Blanco, I
- Lozano, J
- Canals, F
- Sieuwerts, A M
- de Weerd, V
- Look, M P
- Puertas, S
- García, N
- Perkins, A S
- Bonifaci, N
- Skowron, M
- Gómez-Baldó, L
- Hernández, V
- Martínez-Aranda, A
- Martínez-Iniesta, M
- Serrat, X
- Cerón, J
- Brunet, J
- Barretina, M P
- Gil, M
- Falo, C
- Fernández, A
- Morilla, I
- Pernas, S
- Plà, M J
- Andreu, X
- Seguí, M A
- Ballester, R
- Castellà, E
- Nellist, M
- Morales, S
- Valls, J
- Velasco, A
- Matias-Guiu, X
- Figueras, A
- Sánchez-Mut, J V
- Sánchez-Céspedes, M
- Cordero, A
- Gómez-Miragaya, J
- Palomero, L
- Gómez, A
- Gajewski, T F
- Cohen, E E W
- Jesiotr, M
- Bodnar, L
- Quintela-Fandino, M
- López-Bigas, N
- Valdés-Mas, R
- Puente, X S
- Viñals, F
- Casanovas, O
- Graupera, M
- Hernández-Losa, J
- Ramón Y Cajal, S
- García-Alonso, L
- Saez-Rodriguez, J
- Esteller, M
- Sierra, A
- Martín-Martín, N
- Matheu, A
- Carracedo, A
- González-Suárez, E
- Nanjundan, M
- Cortés, J
- Lázaro, C
- Odero, M D
- Martens, J W M
- Moreno-Bueno, G
- Barcellos-Hoff, M H
- Villanueva, A
- Gomis, R R
- Pujana, M A
Producer: 20170907
In:
Oncogene vol. 36
Availability: No items available.
|